What the ACIP considers a minimal burden could increase rapidly, with dire consequences.

FORBES: Immunizing Bureaucrats Against Complacency

Fortunately, ACIP was persuaded by the many stories of pain, loss and devastation shared by the victims, parents and families of this grisly disease.

FORBES: The Government Is Dragging Its Feet on New Vaccines

Beginning in 2009, ACIP began evaluating an infant meningitis vaccine and sent clear signals that it was inclined not to recommend routine use for children under two.

FORBES: Will Little-Known Federal Advisory Panel Deprive Infants Of Meningitis Vaccine?

But while the ACIP is scheduled to meet later this month as it does three times a year it has only scheduled time for discussion, not for a vote to recommend Prevnar 13.

FORBES: The Government Is Dragging Its Feet on New Vaccines